Hankyel Park

Array ( [id] => 4203401 [patent_doc_number] => 06077662 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Virus-like particles, methods and immunogenic compositions' [patent_app_type] => 1 [patent_app_number] => 8/980050 [patent_app_country] => US [patent_app_date] => 1997-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 11978 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077662.pdf [firstpage_image] =>[orig_patent_app_number] => 980050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446321 [patent_doc_number] => 06368788 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Method of treating complications in immunodepressed states resulting from HIV infection' [patent_app_type] => B1 [patent_app_number] => 08/977279 [patent_app_country] => US [patent_app_date] => 1997-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 73207 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368788.pdf [firstpage_image] =>[orig_patent_app_number] => 08977279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3993526 [patent_doc_number] => 05858369 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Anti-acids secretory recombinant BCG vaccine' [patent_app_type] => 1 [patent_app_number] => 8/975699 [patent_app_country] => US [patent_app_date] => 1997-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 14001 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858369.pdf [firstpage_image] =>[orig_patent_app_number] => 975699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4141004 [patent_doc_number] => 06030832 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Carboxy-terminal BRCA1 interacting protein' [patent_app_type] => 1 [patent_app_number] => 8/975703 [patent_app_country] => US [patent_app_date] => 1997-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 28020 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030832.pdf [firstpage_image] =>[orig_patent_app_number] => 975703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3960533 [patent_doc_number] => 05885580 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Anti-AIDS secretory recombinant BCG vaccine' [patent_app_type] => 1 [patent_app_number] => 8/972089 [patent_app_country] => US [patent_app_date] => 1997-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 13805 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885580.pdf [firstpage_image] =>[orig_patent_app_number] => 972089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4101459 [patent_doc_number] => 06051410 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Self-assembled, defective, nonself-propagating viral particles' [patent_app_type] => 1 [patent_app_number] => 8/958906 [patent_app_country] => US [patent_app_date] => 1997-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8437 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051410.pdf [firstpage_image] =>[orig_patent_app_number] => 958906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4120756 [patent_doc_number] => 06072041 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Fusion proteins for protein delivery' [patent_app_type] => 1 [patent_app_number] => 8/957333 [patent_app_country] => US [patent_app_date] => 1997-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 11082 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/072/06072041.pdf [firstpage_image] =>[orig_patent_app_number] => 957333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407562 [patent_doc_number] => 06228621 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Plasmids encoding immunogenic proteins and intracellular targeting sequences' [patent_app_type] => 1 [patent_app_number] => 8/957001 [patent_app_country] => US [patent_app_date] => 1997-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 15625 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228621.pdf [firstpage_image] =>[orig_patent_app_number] => 957001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407528 [patent_doc_number] => 06228618 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof' [patent_app_type] => 1 [patent_app_number] => 8/955526 [patent_app_country] => US [patent_app_date] => 1997-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4999 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228618.pdf [firstpage_image] =>[orig_patent_app_number] => 955526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4248097 [patent_doc_number] => 06207397 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'In vitro fluorescence polarization assay' [patent_app_type] => 1 [patent_app_number] => 8/955650 [patent_app_country] => US [patent_app_date] => 1997-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 16355 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207397.pdf [firstpage_image] =>[orig_patent_app_number] => 955650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4142879 [patent_doc_number] => 06060587 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle' [patent_app_type] => 1 [patent_app_number] => 8/949202 [patent_app_country] => US [patent_app_date] => 1997-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 5 [patent_no_of_words] => 14264 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060587.pdf [firstpage_image] =>[orig_patent_app_number] => 949202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4194652 [patent_doc_number] => 06043347 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Compositions and methods for treating viral infections' [patent_app_type] => 1 [patent_app_number] => 8/948782 [patent_app_country] => US [patent_app_date] => 1997-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27837 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043347.pdf [firstpage_image] =>[orig_patent_app_number] => 948782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4093462 [patent_doc_number] => 06096537 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Cells with multiple altered epitopes on a surface antigen for use in transplantation' [patent_app_type] => 1 [patent_app_number] => 8/946637 [patent_app_country] => US [patent_app_date] => 1997-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 8147 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096537.pdf [firstpage_image] =>[orig_patent_app_number] => 946637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4027384 [patent_doc_number] => 05994055 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'HIV trans-activator Tat binding to CDK7 and activation of CTD phosphorylation' [patent_app_type] => 1 [patent_app_number] => 8/943495 [patent_app_country] => US [patent_app_date] => 1997-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9405 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994055.pdf [firstpage_image] =>[orig_patent_app_number] => 943495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4137387 [patent_doc_number] => 06060235 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Antiviral polymers comprising acid functional groups and hydrophobic groups' [patent_app_type] => 1 [patent_app_number] => 8/934313 [patent_app_country] => US [patent_app_date] => 1997-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4145 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060235.pdf [firstpage_image] =>[orig_patent_app_number] => 934313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151214 [patent_doc_number] => 06107020 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Model for protective and pathogenic roles of HIV-1 env-directed antibody dependent cellular cytotoxicity interaction with viral load, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/932674 [patent_app_country] => US [patent_app_date] => 1997-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 16948 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107020.pdf [firstpage_image] =>[orig_patent_app_number] => 932674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4042744 [patent_doc_number] => 05968542 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'High viscosity liquid controlled delivery system as a device' [patent_app_type] => 1 [patent_app_number] => 8/944022 [patent_app_country] => US [patent_app_date] => 1997-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 10565 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968542.pdf [firstpage_image] =>[orig_patent_app_number] => 944022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1564722 [patent_doc_number] => 06338953 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-15 [patent_title] => 'Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein' [patent_app_type] => B1 [patent_app_number] => 08/927317 [patent_app_country] => US [patent_app_date] => 1997-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 27 [patent_no_of_words] => 28619 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/338/06338953.pdf [firstpage_image] =>[orig_patent_app_number] => 08927317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4274352 [patent_doc_number] => 06281009 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Use of a non-mammalian DNA virus to express an exogenous gene in a mammalian cell' [patent_app_type] => 1 [patent_app_number] => 8/927318 [patent_app_country] => US [patent_app_date] => 1997-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 25 [patent_no_of_words] => 21258 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281009.pdf [firstpage_image] =>[orig_patent_app_number] => 927318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4024637 [patent_doc_number] => 05925751 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Human cytomegalovirus DNA sequences' [patent_app_type] => 1 [patent_app_number] => 8/926922 [patent_app_country] => US [patent_app_date] => 1997-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 27 [patent_no_of_words] => 25892 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925751.pdf [firstpage_image] =>[orig_patent_app_number] => 926922 [rel_patent_id] =>[rel_patent_doc_number] =>)